MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+12.54%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$567M
AUM Growth
+$567M
(+137%)
Cap. Flow
+$334M
Cap. Flow
% of AUM
58.98%
Top 10 Holdings %
Top 10 Hldgs %
88.03%
Holding
104
New
29
Increased
3
Reduced
10
Closed
60
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$119M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$118M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$74.2M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
$55M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$38.8M |
Top Sells
| 1 |
Structure Therapeutics
GPCR
|
$18M |
| 2 |
Arm
ARM
|
$11.8M |
| 3 |
Seagate
STX
|
$7.58M |
| 4 |
Alight
ALIT
|
$6.79M |
| 5 |
Maplebear
CART
|
$6.07M |
Sector Composition
| 1 | Healthcare | 9.08% |
| 2 | Utilities | 1.25% |
| 3 | Industrials | 1.19% |
| 4 | Energy | 0.8% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kinetik
KNTK
$2.55B
| $2.17M | 0.38% |
+64,900
| New | +$2.17M |
|
27
Klaviyo
KVYO
$9.37B
| $1.92M | 0.34% |
68,974
-91,766
| -57% | -$2.55M |
|
28
Aura Biosciences
AURA
$394M
| $1.76M | 0.31% |
+198,415
| New | +$1.76M |
|
29
HCI Group
HCI
$2.21B
| $1.73M | 0.31% |
+19,790
| New | +$1.73M |
|
30
Corebridge Financial
CRBG
$18.5B
| $1.62M | 0.29% |
+75,000
| New | +$1.62M |
|
31
89bio
ETNB
$1.37B
| $1.56M | 0.28% |
+140,000
| New | +$1.56M |
|
32
Runway Growth Finance
RWAY
$390M
| $1.16M | 0.2% |
+91,739
| New | +$1.16M |
|
|
ALPN
33
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $964K | 0.17% |
+74,792
| New | +$964K |
|
34
Myriad Genetics
MYGN
$633M
| $957K | 0.17% |
+50,000
| New | +$957K |
|
35
Compass Therapeutics
CMPX
$466M
| $780K | 0.14% |
500,000
-726,142
| -59% | -$1.13M |
|
36
Shattuck Labs
STTK
$61.3M
| $713K | 0.13% |
+100,000
| New | +$713K |
|
37
AN2 Therapeutics
ANTX
$35.3M
| $697K | 0.12% |
33,997
-65,498
| -66% | -$1.34M |
|
|
BLUE
38
DELISTED
bluebird bio
BLUE
| $690K | 0.12% |
+500,000
| New | +$690K |
|
39
Wave Life Sciences
WVE
$1.27B
| $522K | 0.09% |
+103,300
| New | +$522K |
|
|
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
| $454K | 0.08% |
121,841
-20,000
| -14% | -$74.6K |
|
41
Cidara Therapeutics
CDTX
$1.61B
| $293K | 0.05% |
369,099
| – | – |
|
42
Vivid Seats
SEAT
$100M
| $190K | 0.03% |
30,000
-20,000
| -40% | -$126K |
|
43
PureCycle Technologies
PCT
$2.39B
| $47.6K | 0.01% |
11,754
| – | – |
|
44
Karyopharm Therapeutics
KPTI
$61.4M
| $34.9K | 0.01% |
+132,435
| New | +$34.9K |
|
|
SLGC
45
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-171,193
| Closed | -$409K |
|
|
IMGN
46
DELISTED
Immunogen Inc
IMGN
| – | – |
-40,000
| Closed | -$635K |
|
|
RYZB
47
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-27,500
| Closed | -$611K |
|
|
CBAY
48
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-75,000
| Closed | -$1.12M |
|
|
SBOW
49
DELISTED
SilverBow Resources, Inc.
SBOW
| – | – |
-85,000
| Closed | -$3.04M |
|
|
SQSP
50
DELISTED
Squarespace, Inc.
SQSP
| – | – |
-55,000
| Closed | -$1.59M |
|